Two Sigma Advisers’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-650
| Closed | -$3.17K | – | 2682 |
|
|
2022
Q4 | $3.17K | Sell |
650
-1,115
| -63% | -$5.43K | ﹤0.01% | 2487 |
|
|
2022
Q3 | $14K | Sell |
1,765
-170
| -9% | -$1.35K | ﹤0.01% | 2464 |
|
|
2022
Q2 | $23K | Sell |
1,935
-8,025
| -81% | -$95.4K | ﹤0.01% | 2542 |
|
|
2022
Q1 | $120K | Buy |
9,960
+1,315
| +15% | +$15.8K | ﹤0.01% | 2477 |
|
|
2021
Q4 | $462K | Sell |
8,645
-6,210
| -42% | -$332K | ﹤0.01% | 1950 |
|
|
2021
Q3 | $820K | Sell |
14,855
-8,270
| -36% | -$457K | ﹤0.01% | 1712 |
|
|
2021
Q2 | $1.32M | Sell |
23,125
-18,355
| -44% | -$1.05M | ﹤0.01% | 1509 |
|
|
2021
Q1 | $2.85M | Buy |
41,480
+11,420
| +38% | +$784K | 0.01% | 1103 |
|
|
2020
Q4 | $1.59M | Buy |
30,060
+14,360
| +91% | +$758K | ﹤0.01% | 1374 |
|
|
2020
Q3 | $980K | Buy |
15,700
+4,600
| +41% | +$287K | ﹤0.01% | 1508 |
|
|
2020
Q2 | $917K | Buy |
11,100
+3,180
| +40% | +$263K | ﹤0.01% | 1614 |
|
|
2020
Q1 | $255K | Buy |
7,920
+3,950
| +99% | +$127K | ﹤0.01% | 2084 |
|
|
2019
Q4 | $197K | Buy |
3,970
+2,160
| +119% | +$107K | ﹤0.01% | 2191 |
|
|
2019
Q3 | $61K | Buy |
1,810
+200
| +12% | +$6.74K | ﹤0.01% | 2145 |
|
|
2019
Q2 | $81K | Buy |
1,610
+640
| +66% | +$32.2K | ﹤0.01% | 2230 |
|
|
2019
Q1 | $60K | Buy |
970
+105
| +12% | +$6.5K | ﹤0.01% | 2224 |
|
|
2018
Q4 | $46K | Buy |
+865
| New | +$46K | ﹤0.01% | 2283 |
|